Progress in Pediatric Cardiology
Volume 22, Issue 1 , Pages 3-8 , May 2006

Detection of congenital heart disease in the first trimester of pregnancy

References 

  1. Allan LD, Crawford DC, Chita SK, Tynan MJ. Prenatal screening for congenital heart disease. Br Med J. 1986;282:1717–1719
  2. Tegnander E, Eik-Nes SH, Johansen OJ, Linker DT. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol. 1995;5:372–380
  3. Crane JP, LeFevre ML, Winborn RC, et al. A randomized trial of prenatal ultrasonography screening: impact on the detection, management and outcome of anomalous fetuses. Am J Obstet Gynecol. 1994;171:392–399
  4. Hoffman JI, Christian R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978;42:641–647
  5. Hyett J, Perdu M, Sharland GK, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital heart defects at 10–14 weeks of gestation: population based cohort study. Br Med J. 1999;318:81–85
  6. Souka AP, Krample E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 2001;18:9–17
  7. Dugoff L, et al. for the FASTER Trial Research Consortium First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). Am J Obstet Gynecol. 2004;191:1446–1451
  8. Hyett J, Moscosco G, Nicolaides KH. Cardiac defects in 1st trimester fetus with trisomy 18. Fetal Diagn Ther. 1995;10:381–386
  9. Zosmer N, Souter VL, Chan CS, Huggon IC, Nicolaides KH. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol. 1999;106:829–833
  10. Bahado-Singh RO, et al. for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group Elevated first-trimester nuchal translucency increases the risk of congenital heart disease. Am J Obstet Gynecol. 2005;192:1357–1361
  11. Hyett J, Moscoso G, Pappanagiotou G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol. 1996;7:245–250
  12. Hyett J, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH. Increased nuchal translucency at 10–14 weeks of gestation ass a marker for major cardiac defects. Ultrasound Obstet Gynecol. 1997;10:242–246
  13. Simpson JM, Sharland GK. Nuchal translucency and congenital heart defects: heart failure or not?. Ultrasound Obstet Gynecol. 2000;16:30–36
  14. Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A. Screening of maternal serum for fetal Down syndrome in the first trimester. N Engl J Med. 1998;338:955–961
  15. Monni G, Zoppi M, Ibba RM, Floris M. Results of measurement of nuchal translucency ultrasound before and after training. Lancet. 1997;350:1631
  16. Mavrides E, Cobain-Sanchez F, Tekay A, et al. Limitations of using first-trimester muchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol. 2001;17:106–110
  17. Makrydimas G, Sotiriadis A, Ioannidids JP. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol. 2003;189:1330–1335
  18. Ghi T, Huggon C, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol. 2001;18:610–614
  19. Iscrin L, Lonalay P, Viot G, et al. Prevalence of the microdeletion 22q11 in newborn infarcts with congenital conotruncal cardiac anomalies. Eur J Pediatr. 1998;157:881–884
  20. Hollis B, Mavrides E, Carvalho JS, Hill L, Dickinson V, Thilaganathan B. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency. Ultrasound Obstet Gynecol. 2001;18:32–34
  21. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol. 1997;10:265–268
  22. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol. 1998;12:380–384
  23. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks. Ultrasound Obstet Gynecol. 1999;14:307–310
  24. Favre R, Cherif Y, Kohler M, et al. The role of fetal nuchal translucency and ductus venosus Doppler at 11–14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol. 2003;21:239–243
  25. Borrell A, Antolin E, Costa D, Farre MT, Martinez JM, Fortuny A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol. 1998;179:1612–1617
  26. Mavrides E, Holden D, Bland JM, Tekay A, Thilaganathan B. Intraobserver and interobserver variability of transabdominal Doppler measurements of the fetal ductus venosus between 10 and 14 weeks of gestation. Ultrasound Obstet Gynecol. 2001;17:306–310
  27. Gembruch U, Knopfle G, Chatterjee M, Bald R, Hansmann M. First trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol. 1990;75:
  28. Dolkart LA, Reimers FT. Transvaginal fetal echocardiography in early pregnancy: normative data. Am J Obstet Gynecol. 1991;165:688–691
  29. Bronshtein M, Zimmer EZ, Milo S, Ho SY, Lorber A, Gerlis LM. Fetal cardiac abnormalities detected by transvaginal sonography at 12–16 weeks gestation. Obstet Gynecol. 1991;78:374–378
  30. Rustico MA, Benettoni A, D'Ottavio G, et al. Early screening for fetal cardiac anomalies by transvaginal echocardiography is an unselected population: the role of operator experience. Ultrasound Obstet Gynecol. 2000;16:614–619
  31. Bronshtein M, Zimmer E. The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol. 2002;19:360–365
  32. Gabriel CC, Galindo A, Martinez JM, et al. Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn. 2002;22:586–593
  33. Haak MC, Twisk J, Van Vugy JMG. How successful is fetal echocardiographic examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol. 2002;20:9–13
  34. Huggon IC, Ghi T, Cook AC, Zosmer N, Allen LD, Nicolaides KH. Fetal cardiac anomalies identified prior to 14 weeks gestation. Ultrasound Obstet Gynecol. 2002;20:22–29

PII: S1058-9813(06)00002-6

doi: 10.1016/j.ppedcard.2006.01.001

Progress in Pediatric Cardiology
Volume 22, Issue 1 , Pages 3-8 , May 2006

Article Tools